| Financial Year |
March 31 2023 |
| Monetary Funds |
866,803,965.20 |
| Held-for-trading Financial Assets |
50,506,301.37 |
| Notes Receivable |
357,792,725.58 |
| Accounts Receivable |
831,334,909.97 |
| Advances to Suppliers |
90,292,899.28 |
| Other Receivables |
32,340,907.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,433,029,795.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,385,931.82 |
| Total Current Assets |
3,762,713,462.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
14,631,784.55 |
| Fixed Assetes |
2,319,479,519.31 |
| Under-construction Projects |
900,515,071.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
303,223,171.42 |
| R&D expenses |
-- |
| Goodwill |
525,869,791.26 |
| Long-Term Deferred and Prepaid Expenses |
5,448,405.75 |
| Deferred Income Tax Assets |
57,010,573.98 |
| Other Non-Current Assets |
68,809,918.86 |
| Sub-Total of Non-Current Assets |
4,198,186,869.60 |
| Total Assets |
7,960,900,331.64 |
| Short-Term Loans |
576,445,702.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
641,252,042.64 |
| Accounts Payable |
533,420,837.45 |
| Accounts Received In Advance |
839,662.21 |
| Employee Compensation Payable |
47,632,505.71 |
| Taxes Payable |
26,304,759.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
303,863,410.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
47,025,174.13 |
| Other Current Liabilities |
266,521,338.83 |
| Sub-Total of Current Liabilities |
2,457,661,745.95 |
| Long-term Loans |
1,423,741,189.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,169,374.53 |
| Other Non-Current Liabilities |
21,946.90 |
| Sub-Total of Non-Current Liabilities |
1,486,838,935.40 |
| Total Liabilities |
3,944,500,681.35 |
| Paid-In Capital(Or Share Stock) |
229,619,667.00 |
| Capital Surplus |
1,707,057,771.04 |
| Surplus Reserve |
83,413,621.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,869,153,175.82 |
| Minority Stockholder's Interest |
116,644,673.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,899,754,976.50 |
| Owner's Equity（Stockholder's Equity） |
4,016,399,650.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,960,900,331.64 |
